During the past decade, Cardiology Partners Clinical Research Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 9 clinical trials were completed, i.e. on average, 128.6% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 4 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiology Partners Clinical Research Institute" #1 sponsor was "Bayer" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Abbott Nutrition" with 1 trials sponsored and "American Regent, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiology Partners Clinical Research Institute" #1 collaborator was "Duke Clinical Research Institute" with 2 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Libra Medical" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Cardiology Partners Clinical Research Institute" are "Cardiovascular Disease" (3 trials), "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Acute Myocardial Infarction" (1 trials) and "Atherosclerotic Cardiovascular Disease" (1 trials). Many other conditions were trialed in "Cardiology Partners Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Cardiology Partners Clinical Research Institute" are "Drug" (11 trials), "Other" (2 trials), "Procedure" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Apixaban" (2 trials), "bococizumab (PF-04950615)" (2 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiology Partners Clinical Research Institute" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Cardiology Partners Clinical Research Institute". undefined are not yet recruiting, 2 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Cardiology Partners Clinical Research Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiology Partners Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".

Cardiology Partners Clinical Research Institute has several departments that took part in Clinical trials: "Cardiology Partners" - 6 trials